Vanda Pharmaceuticals
VNDA
#7582
Rank
NZ$0.71 B
Marketcap
NZ$11.86
Share price
-1.41%
Change (1 day)
54.51%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -NZ$0.21 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.21 Billion. In 2024 the company made an earning of -NZ$68.92 Million a decrease over its 2023 earnings that were of -NZ$23.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.21 Billion201.48%
2024 -NZ$68.92 Million191.43%
2023 -NZ$23.65 Million-320.45%
2022 NZ$10.72 M-84.99%
2021 NZ$71.46 M54.8%
2020 NZ$46.16 M19.42%
2019 NZ$38.65 M4.93%
2018 NZ$36.84 M-228.6%
2017 -NZ$28.65 Million-8.98%
2016 -NZ$31.48 Million-53.79%
2015 -NZ$68.11 Million-30.18%
2014 -NZ$97.55 Million173.08%
2013 -NZ$35.72 Million-25.33%
2012 -NZ$47.84 Million163.61%
2011 -NZ$18.15 Million-221.15%
2010 NZ$14.97 M-124.53%
2009 -NZ$61.07 Million-29.44%
2008 -NZ$86.55 Million-36.2%
2007 -NZ$0.14 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$41.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$56.86 B-27,807.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.71 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.27 B-8,516.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$43.60 B-21,348.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.00 B-18,617.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$15.80 B-7,803.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-NZ$4.76 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA